Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Pharmaceuticals (@TevaUSA) / Twitter
Fallout from Teva plant closings, global layoffs continues in Israel | Fierce Pharma
Teva gets exclusivity on Plan B contraceptive - The Boston Globe
Teva Pharmaceuticals resolves bribery case with Israel authorities | The FCPA Blog
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges
Teva's loss is Israeli pharma industry's gain - Globes
Teva agrees to tentative $4.25 billion national settlement over opioids - The Boston Globe
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Brand-name drug group accepts Teva, a maker of generics - The Boston Globe
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals to cut 25 percent of jobs in huge reshaping - The Boston Globe
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva meets profit expectations but misses on revenue - Globes
Asia Deal Watch: Astellas Begins 2023 Signing Rare Disease Tie-Ups With Selecta, Twist :: Scrip
Fresh woes emerge as Teva plunges to new lows - Globes